Table of contents
Volume 90, Issue 12
Published online 8 June 2004 (2249-2441)
Minireview |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Erratum |
Author Index |
Keyword Index
Editorial
Editorial FREE
R A Weiss, Editor-in-Chief
Br J Cancer 90: 2249; doi:10.1038/sj.bjc.6601940
Minireview
Epidermal growth factor receptor tyrosine kinase inhibitors FREE
M Ranson
Br J Cancer 90: 2250-2255; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601873
Clinical
Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society FREE
J E Husband, L H Schwartz, J Spencer, L Ollivier, D M King, R Johnson and R Reznek on behalf of the Membership of the International Cancer Imaging Society
Br J Cancer 90: 2256-2260; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601843
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours FREE
F M Wachters, H J M Groen, J G Maring, J A Gietema, M Porro, H Dumez, E G E de Vries and A T van Oosterom
Br J Cancer 90: 2261-2267; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601811
Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks FREE
T Kerbusch, G Groenewegen, R A A Mathôt, V M M Herben, W W ten Bokkel Huinink, M Swart, B Ambaum, H Rosing, S Jansen, E E Voest, J H Beijnen and J H M Schellens
Br J Cancer 90: 2268-2277; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601861
Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy FREE
C McGough, C Baldwin, G Frost and H J N Andreyev
Br J Cancer 90: 2278-2287; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601868
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer FREE
M Di Maio, C Gridelli, C Gallo, L Manzione, L Brancaccio, S Barbera, S F Robbiati, G P Ianniello, F Ferraù, E Piazza, L Frontini, F Rosetti, F Carrozza, A Bearz, M Spatafora, V Adamo, L Isa, R V Iaffaioli, E Di Salvo and F Perrone
Br J Cancer 90: 2288-2296; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601810
High levels of untreated distress and fatigue in cancer patients FREE
L E Carlson, M Angen, J Cullum, E Goodey, J Koopmans, L Lamont, J H MacRae, M Martin, G Pelletier, J Robinson, J S A Simpson, M Speca, L Tillotson and B D Bultz
Br J Cancer 90: 2297-2304; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601887
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG) FREE
J Classen, H Schmidberger, C Meisner, C Winkler, J Dunst, R Souchon, L Weissbach, V Budach, W Alberti and M Bamberg
Br J Cancer 90: 2305-2311; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601867
Serum levels of IL-6 and TNF-
correlate with clinicopathological features and patient survival in patients with prostate cancer FREE
V Michalaki, K Syrigos, P Charles and J Waxman
Br J Cancer 90: 2312-2316; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601814
Hormonal impact of the 17-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer FREE
A O'Donnell, I Judson, M Dowsett, F Raynaud, D Dearnaley, M Mason, S Harland, A Robbins, G Halbert, B Nutley and M Jarman
Br J Cancer 90: 2317-2325; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601879
Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome FREE
N M deSouza, W P Soutter, G Rustin, M M Mahon, B Jones, R Dina and G A McIndoe
Br J Cancer 90: 2326-2331; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601870
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients FREE
S Houterman, M L G Janssen-Heijnen, C D G W Verheij, W J Louwman, G Vreugdenhil, M J C van der Sangen and J W W Coebergh
Br J Cancer 90: 2332-2337; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601844
Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer FREE
M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata and S Ohno
Br J Cancer 90: 2338-2343; advance online publication, May 4, 2004; doi:10.1038/sj.bjc.6601845
Molecular and Cellular Pathology
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review FREE
J Carlsson, H Nordgren, J Sjöström, K Wester, K Villman, N O Bengtsson, B Ostenstad, H Lundqvist and C Blomqvist
Br J Cancer 90: 2344-2348; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601881
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis FREE
W Wang, L-Y Yang, G-W Huang, W-Q Lu, Z-L Yang, J-Q Yang and H-L Liu
Br J Cancer 90: 2349-2355; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601749
Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients FREE
C Djuzenova, B Mühl, R Schakowski, U Oppitz and M Flentje
Br J Cancer 90: 2356-2363; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601878
Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling FREE
K Renaudin, M G Denis, G Karam, G Vallette, F Buzelin, C L Laboisse and A Jarry
Br J Cancer 90: 2364-2369; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601809
Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells FREE
S Hövelmann, T L Beckers and M Schmidt
Br J Cancer 90: 2370-2377; advance online publication, May 11, 2004; doi:10.1038/sj.bjc.6601876
Genetics and Genomics
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers FREE
Y-C Lee, C-T Wu, J-Y Shih, Y-S Jou and Y-L Chang
Br J Cancer 90: 2378-2383; advance online publication, May 4, 2004; doi:10.1038/sj.bjc.6601778
Candidate target genes for loss of heterozygosity on human chromosome 17q21 FREE
L DeMarchis, C Cropp, Z M Sheng, S Bargo and R Callahan
Br J Cancer 90: 2384-2389; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601848
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma FREE
P H Yin, H C Lee, G Y Chau, Y T Wu, S H Li, W Y Lui, Y H Wei, T Y Liu and C W Chi
Br J Cancer 90: 2390-2396; advance online publication, May 4, 2004; doi:10.1038/sj.bjc.6601838
Somatic mutations of KIT in familial testicular germ cell tumours FREE
E A Rapley, S Hockley, W Warren, L Johnson, R Huddart, G Crockford, D Forman, M G Leahy, D T Oliver, K Tucker, M Friedlander, K-A Phillips, D Hogg, M A S Jewett, R Lohynska, G Daugaard, S Richard, A Heidenreich, L Geczi, I Bodrogi, E Olah, W J Ormiston, P A Daly, L H J Looijenga, P Guilford, N Aass, S D Fosså, K Heimdal, S A Tjulandin, L Liubchenko, H Stoll, W Weber, L Einhorn, B L Weber, M McMaster, M H Greene, D T Bishop, D Easton and M R Stratton
Br J Cancer 90: 2397-2401; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601880
Experimental Therapeutics
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT) FREE
A Mayer, S K Sharma, B Tolner, N P Minton, D Purdy, P Amlot, G Tharakan, R H J Begent and K A Chester
Br J Cancer 90: 2402-2410; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601888
Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation FREE
R Boonstra, H Timmer-Bosscha, J van Echten-Arends, D M van der Kolk, A van den Berg, B de Jong, K D Tew, S Poppema and E G E de Vries
Br J Cancer 90: 2411-2417; advance online publication, May 18, 2004; doi:10.1038/sj.bjc.6601863
Antiangiogenic activity of aplidine, a new agent of marine origin FREE
G Taraboletti, M Poli, R Dossi, L Manenti, P Borsotti, G T Faircloth, M Broggini, M D'Incalci, D Ribatti and R Giavazzi
Br J Cancer 90: 2418-2424; advance online publication, June 1, 2004; doi:10.1038/sj.bjc.6601864
Erratum
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–RCR and immunohistochemical analysis FREE
M Thomasson, H Hedman, D Guo, B Ljungberg and R Henriksson
Br J Cancer 90: 2425; doi:10.1038/sj.bjc.6601773
Author Index
Author Index for Volume 90 FREE
Br J Cancer 90: 2426-2433; doi:10.1038/sj.bjc.6601977
Keyword Index
Keyword Index for Volume 90 FREE
Br J Cancer 90: 2436-2441; doi:10.1038/sj.bjc.6601978
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
